Literature DB >> 2998245

Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogeneic bone marrow transplantation.

C Cordonnier, J F Bernaudin, J Fleury, M Feuilhade, C Haioun, D Payen, Y Huet, K Atassi, J P Vernant.   

Abstract

Fifty-two bronchoalveolar lavages (BAL) were performed in order to investigate 46 episodes of pneumonitis that occurred after allogeneic bone-marrow transplantation. No complications have been attributed to this procedure. A specific etiologic diagnosis was obtained in 24 of 46 episodes (52%) by 26 of 52 BAL (50%). Cytomegalovirus (CMV), diagnosed by the presence of typical inclusions, was the pathogen most frequently identified by BAL (13 of 46 episodes) and was associated with other causes of pneumonia in 4 patients. The other causes of pneumonitis diagnosed by BAL were: giant-cell pneumonia: 1, aspergillosis alone: 3, Pneumocystis carinii: 1, Hemophilus influenzae: 3, isolated pulmonary hemorrhage: 3. One false negative (aspergillosis, n = 1) was diagnosed at autopsy. The overall mortality rate of these episodes was 24%. Thus, BAL appears to be a rapid and reproducible diagnostic method for monitoring pneumonitis in grafted patients, particularly CMV pneumonitis, and may avoid the need for surgical biopsy.

Entities:  

Mesh:

Year:  1985        PMID: 2998245     DOI: 10.1164/arrd.1985.132.5.1118

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  12 in total

1.  Bronchoscopic aspiration and bronchoalveolar lavage in the diagnosis of sputum smear-negative pulmonary tuberculosis.

Authors:  H S Chan; A J Sun; G B Hoheisel
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

3.  Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimen.

Authors:  I A Hohenadel; M Kiworr; R Genitsariotis; D Zeidler; J Lorenz
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

Review 4.  Secondary alveolar proteinosis in cancer patients.

Authors:  S Ladeb; J Fleury-Feith; E Escudier; J Tran Van Nhieu; J F Bernaudin; C Cordonnier
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

5.  Is intensive care justified for patients with haematological malignancies?

Authors:  F Brunet; J J Lanore; J F Dhainaut; F Dreyfus; J F Vaxelaire; S Nouira; T Giraud; A Armaganidis; J F Monsallier
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

6.  Utility of bronchoscopy with bronchoalveolar lavage in diagnosing pulmonary infection in hospitalized patients with underlying malignancy.

Authors:  C Chow; A McGeer; G Kasupski; N Senathiragah; P Gallant; C Chan
Journal:  Can J Infect Dis       Date:  1998-03

7.  [Pneumonia in immunocompromised patients: the value of non-biopsy bronchoscopic examination procedures in the diagnosis of pathogens].

Authors:  M von Eiff; R Steimann; N Roos; N van Husen; P Walger; P Baumgart; W Fegeler; E Junge; H Baumeister; B Wilms
Journal:  Klin Wochenschr       Date:  1990-04-02

8.  Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study.

Authors:  Fotis Sampsonas; Dimitrios P Kontoyiannis; Burton F Dickey; Scott E Evans
Journal:  Cancer       Date:  2011-01-18       Impact factor: 6.860

9.  Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR.

Authors:  S Bretagne; J M Costa; A Marmorat-Khuong; F Poron; C Cordonnier; M Vidaud; J Fleury-Feith
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  Analysis of bronchoalveolar lavage specimens from immunocompromised patients with a protocol applicable in the microbiology laboratory.

Authors:  F W Kahn; J M Jones
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.